NASDAQ:PCRX - Pacira Biosciences News Headlines

$37.63
-0.52 (-1.36 %)
(As of 09/17/2019 08:00 AM ET)
Today's Range
$37.28
Now: $37.63
$38.10
50-Day Range
$35.77
MA: $39.27
$44.43
52-Week Range
$34.64
Now: $37.63
$55.00
Volume465,500 shs
Average Volume464,972 shs
Market Capitalization$1.57 billion
P/E Ratio129.76
Dividend YieldN/A
Beta1.13

Headlines

Pacira Biosciences (NASDAQ PCRX) News Headlines

Source:
DateHeadline
Pacira Biosciences Inc (NASDAQ:PCRX) Given Average Recommendation of "Hold" by BrokeragesPacira Biosciences Inc (NASDAQ:PCRX) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - September 11 at 2:30 AM
Pacira (PCRX) Down 15.3% Since Last Earnings Report: Can It Rebound?Pacira (PCRX) Down 15.3% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - September 7 at 2:23 PM
Is Pacira BioSciences (NASDAQ:PCRX) A Risky Investment?Is Pacira BioSciences (NASDAQ:PCRX) A Risky Investment?
finance.yahoo.com - September 5 at 1:40 PM
$105.45 Million in Sales Expected for Pacira Biosciences Inc (NASDAQ:PCRX) This Quarter$105.45 Million in Sales Expected for Pacira Biosciences Inc (NASDAQ:PCRX) This Quarter
www.americanbankingnews.com - September 3 at 1:04 AM
$0.35 Earnings Per Share Expected for Pacira Biosciences Inc (NASDAQ:PCRX) This Quarter$0.35 Earnings Per Share Expected for Pacira Biosciences Inc (NASDAQ:PCRX) This Quarter
www.americanbankingnews.com - September 2 at 12:10 AM
Oversold Conditions For Pacira BioSciencesOversold Conditions For Pacira BioSciences
www.nasdaq.com - August 16 at 7:45 PM
Pacira (PCRX) Beats Q2 Earnings and Revenue EstimatesPacira (PCRX) Beats Q2 Earnings and Revenue Estimates
finance.yahoo.com - August 9 at 12:00 AM
Pacira Pharmaceuticals, Inc. (PCRX) Q2 2019 Earnings Call TranscriptPacira Pharmaceuticals, Inc. (PCRX) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 9 at 12:00 AM
Pacira BioSciences Reports Second Quarter 2019 Financial Results and Business UpdatePacira BioSciences Reports Second Quarter 2019 Financial Results and Business Update
finance.yahoo.com - August 8 at 8:34 AM
Pacira BioSciences to Present at the 2019 Wedbush Pacgrow Healthcare ConferencePacira BioSciences to Present at the 2019 Wedbush Pacgrow Healthcare Conference
finance.yahoo.com - August 7 at 8:06 PM
Should You Be Concerned About Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Historical Volatility?Should You Be Concerned About Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Historical Volatility?
finance.yahoo.com - July 31 at 8:39 AM
Pacira to Report Second Quarter 2019 Financial Results on Thursday August 8, 2019Pacira to Report Second Quarter 2019 Financial Results on Thursday August 8, 2019
finance.yahoo.com - July 30 at 10:12 AM
Pacira (PCRX) Earnings Expected to Grow: Should You Buy?Pacira (PCRX) Earnings Expected to Grow: Should You Buy?
finance.yahoo.com - July 26 at 1:01 AM
Pacira BioSciences Becomes Oversold (PCRX)Pacira BioSciences Becomes Oversold (PCRX)
www.nasdaq.com - July 22 at 6:55 PM
DRRX: Favorable FDA Decision on POSIMIR Would Likely Mean Significant Upside to Our ModelDRRX: Favorable FDA Decision on POSIMIR Would Likely Mean Significant Upside to Our Model
finance.yahoo.com - June 28 at 6:01 PM
EMA accepts Paciras application for Exparel for postsurgical painEMA accepts Pacira's application for Exparel for postsurgical pain
seekingalpha.com - June 25 at 11:10 AM
Is Pacira BioSciences, Inc. (NASDAQ:PCRX) Trading At A 36% Discount?Is Pacira BioSciences, Inc. (NASDAQ:PCRX) Trading At A 36% Discount?
finance.yahoo.com - June 25 at 11:10 AM
Pacira BioSciences Announces Validation of EXPAREL Marketing Authorization Application from European Medicines AgencyPacira BioSciences Announces Validation of EXPAREL Marketing Authorization Application from European Medicines Agency
finance.yahoo.com - June 25 at 11:10 AM
Pacira BioSciences Appoints Former Johnson & Johnson Executive, Max Reinhardt, as PresidentPacira BioSciences Appoints Former Johnson & Johnson Executive, Max Reinhardt, as President
finance.yahoo.com - June 19 at 9:21 AM
Here’s What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)Here’s What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
finance.yahoo.com - June 14 at 6:59 PM
New Analysis Shows Use of EXPAREL Associated with Improved Clinical and Economic Outcomes Following Hip Replacement SurgeryNew Analysis Shows Use of EXPAREL Associated with Improved Clinical and Economic Outcomes Following Hip Replacement Surgery
finance.yahoo.com - June 12 at 11:36 AM
Why Is Pacira (PCRX) Down 7.2% Since Last Earnings Report?Why Is Pacira (PCRX) Down 7.2% Since Last Earnings Report?
finance.yahoo.com - June 1 at 5:15 PM
Pacira BioSciences to Present at the Jefferies 2019 Healthcare ConferencePacira BioSciences to Present at the Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 28 at 8:52 AM
How Financially Strong Is Pacira BioSciences, Inc. (NASDAQ:PCRX)?How Financially Strong Is Pacira BioSciences, Inc. (NASDAQ:PCRX)?
finance.yahoo.com - May 22 at 6:52 PM
JAZZ vs. PCRX: Which Stock Should Value Investors Buy Now?JAZZ vs. PCRX: Which Stock Should Value Investors Buy Now?
finance.yahoo.com - May 20 at 10:45 AM
Edited Transcript of PCRX earnings conference call or presentation 2-May-19 12:30pm GMTEdited Transcript of PCRX earnings conference call or presentation 2-May-19 12:30pm GMT
finance.yahoo.com - May 3 at 6:49 PM
Pacira Pharmaceuticals, Inc. (PCRX) Q1 2019 Earnings Call TranscriptPacira Pharmaceuticals, Inc. (PCRX) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 3 at 6:49 PM
Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug ExparelPacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel
finance.yahoo.com - May 3 at 9:00 AM
Pacira (PCRX) Misses Q1 Earnings EstimatesPacira (PCRX) Misses Q1 Earnings Estimates
finance.yahoo.com - May 2 at 7:34 PM
Pacira BioSciences Reports First Quarter 2019 Revenues of $91.3 MillionPacira BioSciences Reports First Quarter 2019 Revenues of $91.3 Million
www.globenewswire.com - May 2 at 9:00 AM
PCRX Crosses Above Key Moving Average LevelPCRX Crosses Above Key Moving Average Level
www.nasdaq.com - May 1 at 7:02 PM
Pacira Pre-Earnings Calls Hot as Rival Biotech SinksPacira Pre-Earnings Calls Hot as Rival Biotech Sinks
finance.yahoo.com - May 1 at 7:02 PM
Herons HTX-011 pain is Paciras gain, up 16% premarketHeron's HTX-011 pain is Pacira's gain, up 16% premarket
seekingalpha.com - May 1 at 8:47 AM
See what the IHS Markit Score report has to say about Pacira Biosciences Inc.See what the IHS Markit Score report has to say about Pacira Biosciences Inc.
finance.yahoo.com - April 30 at 8:50 AM
Why the Earnings Surprise Streak Could Continue for Pacira (PCRX)Why the Earnings Surprise Streak Could Continue for Pacira (PCRX)
finance.yahoo.com - April 26 at 6:32 PM
Pacira (PCRX) to Report Q1 Results: Wall Street Expects Earnings GrowthPacira (PCRX) to Report Q1 Results: Wall Street Expects Earnings Growth
finance.yahoo.com - April 25 at 6:44 PM
Pacira to Report First Quarter 2019 Financial Results on Thursday May 2, 2019Pacira to Report First Quarter 2019 Financial Results on Thursday May 2, 2019
finance.yahoo.com - April 25 at 8:49 AM
Read This Before Selling Pacira BioSciences, Inc. (NASDAQ:PCRX) SharesRead This Before Selling Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares
finance.yahoo.com - April 22 at 5:52 PM
Pacira Completes Acquisition of MyoScience, Advancing Leadership in Non-opioid Pain Management with FDA-approved ioveraº SystemPacira Completes Acquisition of MyoScience, Advancing Leadership in Non-opioid Pain Management with FDA-approved ioveraº System
finance.yahoo.com - April 9 at 9:21 PM
Why Is Pacira (PCRX) Down 7.6% Since Last Earnings Report?Why Is Pacira (PCRX) Down 7.6% Since Last Earnings Report?
finance.yahoo.com - March 30 at 6:16 PM
Pacira's New Steps to Pain TreatmentPacira's New Steps to Pain Treatment
finance.yahoo.com - March 25 at 7:02 PM
Did Changing Sentiment Drive Pacira Pharmaceuticals’s (NASDAQ:PCRX) Share Price Down By 43%?Did Changing Sentiment Drive Pacira Pharmaceuticals’s (NASDAQ:PCRX) Share Price Down By 43%?
finance.yahoo.com - March 15 at 6:59 PM
New Analysis Shows Enhanced Recovery Pathway Including EXPAREL Infiltration Facilitates Rapid Discharge, High Satisfaction, and Limited Opioid Use in Medicare Patients Undergoing Total Joint ReplacementNew Analysis Shows Enhanced Recovery Pathway Including EXPAREL Infiltration Facilitates Rapid Discharge, High Satisfaction, and Limited Opioid Use in Medicare Patients Undergoing Total Joint Replacement
finance.yahoo.com - March 13 at 9:53 AM
Pacira to Acquire MyoScience, Adding FDA-approved ioveraº System for Non-opioid Pain ControlPacira to Acquire MyoScience, Adding FDA-approved ioveraº System for Non-opioid Pain Control
finance.yahoo.com - March 6 at 9:07 AM
[$$] Pacira Pharmaceuticals Strikes $220 Million Deal to Buy Myoscience[$$] Pacira Pharmaceuticals Strikes $220 Million Deal to Buy Myoscience
finance.yahoo.com - March 5 at 6:22 PM
Pacira stock down 1.9% after announcing MyoScience acquisitionPacira stock down 1.9% after announcing MyoScience acquisition
www.marketwatch.com - March 5 at 9:17 AM
Pacira stock down 1.9% after company announces MyoScience acquisitionPacira stock down 1.9% after company announces MyoScience acquisition
finance.yahoo.com - March 5 at 9:17 AM
Edited Transcript of PCRX earnings conference call or presentation 28-Feb-19 1:30pm GMTEdited Transcript of PCRX earnings conference call or presentation 28-Feb-19 1:30pm GMT
finance.yahoo.com - March 2 at 5:57 PM
Pacira Pharmaceuticals Inc.Pacira Pharmaceuticals Inc.
www.barrons.com - February 28 at 6:36 PM
Pacira Pharmaceuticals Inc (PCRX) Q4 2018 Earnings Conference Call TranscriptPacira Pharmaceuticals Inc (PCRX) Q4 2018 Earnings Conference Call Transcript
www.fool.com - February 28 at 2:32 PM
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Featured Article: Liquidity

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel